CASI Pharmaceuticals (CASI.US) Latest Stock News - Major News Analysis

Event Tracking

Nov15

CASI Pharmaceuticals released FY2025 9 Months Earnings on November 14 (EST), actual revenue USD 13.49 M, actual EPS USD -2.2345

04:00

CASI Pharmaceuticals released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 3.075 M (forecast USD 0), actual EPS USD -0.678 (forecast USD -0.4)

04:00

Aug30

CASI Pharmaceuticals released FY2025 Semi-Annual earnings on August 29 (EST), actual revenue USD 10.42 M, actual EPS USD -1.5565

03:00

CASI Pharmaceuticals released FY2025 Q2 earnings on August 29 (EST), actual revenue USD 4.175M (forecast USD 6.275M), actual EPS USD -0.8625 (forecast USD -0.47)

03:00

Aug29

CASI Pharmaceuticals Reports Q2 2025 Revenue Growth and Increased Net Loss

20:05

Aug27

CASI Pharmaceuticals' FOLOTYN® Import License in China Has Expired

20:52